We are live on ! Find out more
SER icon

Serina Therapeutics
SER

32 hedge funds and large institutions have $4.09M invested in Serina Therapeutics in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0.36% → 0.36% (-0%)

9% less funds holding

Funds holding: 35 → 32 (-3)

23% less capital invested

Capital invested by funds: $5.28M → $4.09M (-$1.19M)

44% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 9

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
5
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Creative Planning
Creative Planning
Kansas
+$16.4K
2
SXL
Summit X LLC
Missouri
+$6.06K
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.33K
4
TRCT
Tower Research Capital (TRC)
New York
+$3.76K
5
SWIG
Strategic Wealth Investment Group
Kentucky
+$2.39K

Top Sellers

1
VF
Virtu Financial
New York
-$36K
2
Jane Street
Jane Street
New York
-$31K
3
Millennium Management
Millennium Management
New York
-$14K
4
UBS Group
UBS Group
Switzerland
-$12.7K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$9.48K
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
26
Virtu Financial
New York
– -$36K -947 Closed
Jane Street
27
Jane Street
New York
– -$31K -799 Closed
UBS Group
28
UBS Group
Switzerland
– -$12.7K -446 -100%
Millennium Management
29
Millennium Management
New York
– -$14K -373 Closed
CA
30
CoreCap Advisors
Michigan
– -$1K – –
1
2

SER Hedge Fund Activity: Q1 2022 in Review

32 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q1 2022, worth a combined $4.09M — down 23% from $5.28M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of SER and 2 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 5 added.

The largest buyer was Creative Planning, adding an estimated $16.4K. The largest seller was Virtu Financial, exiting entirely with an estimated $36K sold.

  • 32 institutional investors held Serina Therapeutics (SER) as of Q1 2022, down from 35 in Q4 2021.
  • Funds reported $4.09M of Serina Therapeutics stock for Q1 2022, down 23% quarter-over-quarter.
  • 2 funds opened new Serina Therapeutics positions in Q1 2022 and 4 closed out, a net change of -2 holders.
  • The largest Serina Therapeutics buyer in Q1 2022 was Creative Planning, an estimated $16.4K added.
  • The largest Serina Therapeutics seller in Q1 2022 was Virtu Financial, an estimated $36K sold.

Based on aggregated 13F filings for Q1 2022.